Effect of TTLL12 on tubulin tyrosine nitration as a novel target for screening anticancer drugs<em> in&nbsp;vitro</em>

Xue,Lingli; Zeng,Yan; Fang,Chuan; Cheng,Wei; Li,Yadong

doi:10.3892/ol.2020.12203

December-2020 Volume 20 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2020 Volume 20 Issue 6

Full Size Image

Article Open Access

Effect of TTLL12 on tubulin tyrosine nitration as a novel target for screening anticancer drugs in vitro

Authors:
- Lingli Xue
- Yan Zeng
- Chuan Fang
- Wei Cheng
- Yadong Li
View Affiliations / Copyright

Affiliations: Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China

Copyright: © Xue et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 340
|
Published online on: October 8, 2020

https://doi.org/10.3892/ol.2020.12203
Expand metrics +

Abstract

Nitrotyrosine, a structural analogue of tyrosine, is present in cells in pathological conditions and is incorporated into tubulin to form tubulin tyrosine nitration, which disrupts the normal function of microtubules. There is limited research on the functional aspects of tubulin tyrosine nitration in different types of tumor. In the present study, the effect of tubulin tyrosine nitration and tubulin tyrosine ligase like 12 (TTLL12) on the proliferation of SCC‑25 cells was investigated. TTLL12‑overexpressing cell lines were constructed and used to assess the effect of tubulin tyrosine nitration and TTLL12 on the proliferation of SCC‑25 cells via western blotting, immunofluorescent and MTT assays. An TTLL12‑stably overexpressing SCC‑25 cell line and the enzyme‑linked immunosorbent assay were used to establish a novel experiment in vitro for screening anticancer drugs targeting tubulin tyrosine nitration by assessing its sensitivity, specificity and repeatability, and using it to find an effective drug. The results demonstrated that the proliferative rate of the control cells was notably inhibited in the presence of nitrotyrosine compared with that of TTLL12‑overexpressing cells. The results of the MTT assay revealed that the proliferation of TTLL12‑silenced cells was significantly inhibited compared with that of the control group. The sensitivity, specificity and repeatability of the experiment were positive. It was found that nocodazole could have better anticancer effect than paclitaxel. Taken together, the results of the present study suggest that TTLL12 enhances SCC‑25 cell survival in the presence of nitrotyrosine by disrupting nitration of the tyrosine residues of tubulin, and tubulin tyrosine nitration may be developed for the basic research of anticancer drugs.

View Figures

View References

1	Anavi S and Tirosh O: iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 146:16–35. 2020. View Article : Google Scholar : PubMed/NCBI
2	Goldstein S and Merényi G: The chemistry of peroxynitrite: Implications for biological activity. Methods Enzymol. 436:49–61. 2008. View Article : Google Scholar : PubMed/NCBI
3	Wang B, Wang Y, Wang Y, Zhao Y, Yang C, Zeng Z, Huan S, Song G and Zhang X: Oxygen-embedded pentacene based near-infrared chemiluminescent nanoprobe for highly selective and sensitive visualization of peroxynitrite in vivo. Anal Chem. 92:4154–4163. 2020. View Article : Google Scholar : PubMed/NCBI
4	Eiserich JP, Estévez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS and Freeman BA: Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: A nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA. 96:6365–6370. 1999. View Article : Google Scholar : PubMed/NCBI
5	Bartesaghi S and Radi R: Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 14:618–625. 2018. View Article : Google Scholar : PubMed/NCBI
6	Tampa M, Mitran MI, Mitran CI, Sarbu MI, Matei C, Nicolae I, Caruntu A, Tocut SM, Popa MI, Caruntu C and Georgescu SR: Mediators of inflammation-A potential source of biomarkers in oral squamous cell carcinoma. J Immunol Res. 2018:10617802018. View Article : Google Scholar : PubMed/NCBI
7	Lee BJ, Chan MY, Hsiao HY, Chang CH, Hsu LP and Lin PT: Relationship of Oxidative Stress, Inflammation, and the Risk of Metabolic Syndrome in Patients with Oral Cancer. Oxid Med Cell Longev. 2018:93030942018. View Article : Google Scholar : PubMed/NCBI
8	Chaiyarit P, Ma N, Hiraku Y, Pinlaor S, Yongvanit P, Jintakanon D, Murata M, Oikawa S and Kawanishi S: Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 96:553–559. 2005. View Article : Google Scholar : PubMed/NCBI
9	Silva Servato JP, Ueira Vieira C, de Faria PR, Cardoso SV and Loyola AM: The importance of inducible nitric oxide synthase and nitrotyrosine as prognostic markers for oral squamous cell carcinoma. J Oral Pathol Med. 48:967–975. 2019. View Article : Google Scholar : PubMed/NCBI
10	Olek M, Kasperski J, Skaba D, Wiench R, Cieślar G and Kawczyk-Krupka A: Photodynamic therapy for the treatment of oral squamous carcinoma-clinical implications resulting from in vitro research. Photodiagnosis Photodyn Ther. 27:255–267. 2019. View Article : Google Scholar : PubMed/NCBI
11	Irani S: Pre-cancerous lesions in the oral and maxillofacial region: A literature reviewwith special focus on etiopathogenesis. Iran J Pathol. 11:303–322. 2016.PubMed/NCBI
12	Vucicevic Boras V, Fucic A, Virag M, Gabric D, Blivajs I, Tomasovic-Loncaric C, Rakusic Z, Bisof V, Novere NL and Velimir Vrdoljak D: Significance of stroma in biology of oral squamous cell carcinoma. Tumori. 104:9–14. 2018. View Article : Google Scholar : PubMed/NCBI
13	Bao X, Liu F, Lin J, Chen Q, Chen L, Chen F, Wang J, Qiu Y, Shi B, Pan L, et al: Nutritional assessment and prognosis of oral cancer patients: A large-scale prospective study. BMC Cancer. 20:1462020. View Article : Google Scholar : PubMed/NCBI
14	Wang SS, Zheng M, Pang X, Zhang M, Yu XH, Wu JB, Gao XL, Wu JS, Yang X, Tang YJ, et al: Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9. Mol Carcinog. 58:1809–1821. 2019. View Article : Google Scholar : PubMed/NCBI
15	Ortiz RC, Lopes NM, Amôr NG, Ponce JB, Schmerling CK, Lara VS, Moyses RA and Rodini CO: CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. J Oral Pathol Med. 47:740–747. 2018. View Article : Google Scholar : PubMed/NCBI
16	Romer CAE, Broglie Daeppen MA, Mueller M, Huber GF, Guesewell S and Stoeckli SJ: Long-term speech and swallowing function after primary resection and sentinel node biopsy for early oral squamous cell carcinoma. Oral Oncol. 89:127–132. 2019. View Article : Google Scholar : PubMed/NCBI
17	Deng W, Yang L, Xie C, Lu H, Xiao Y, Zeng B, Liang Y and Liao G: Prediction of postoperative lower respiratory tract infections in tongue cancer patients based on pretreatment swallowing function. Oral Dis. 26:537–546. 2020. View Article : Google Scholar : PubMed/NCBI
18	Goswami S and Gupta SS: How cancer of oral cavity affects the family caregivers? -A cross-sectional study in Wardha, India, using the caregiver quality of life index-cancer questionnaire. South Asian J Cancer. 9:62–65. 2020. View Article : Google Scholar : PubMed/NCBI
19	Sun Y, Liu N, Guan X, Wu H, Sun Z and Zeng H: Immunosuppression induced by chronic inflammation and the progression to oral squamous cell carcinoma. Mediators Inflamm. 2016:57157192016. View Article : Google Scholar : PubMed/NCBI
20	Xu L, Hou TJ and Yang P: Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a. Eur Rev Med Pharmacol Sci. 23:6505–6515. 2019.PubMed/NCBI
21	Xiao T, Sun J, Xing Z, Xie F, Yang L and Ding W: MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production. Cell Biol Int. 44:821–829. 2020. View Article : Google Scholar : PubMed/NCBI
22	Sanada H, Seki N, Mizuno K, Misono S, Uchida A, Yamada Y, Moriya S, Kikkawa N, Machida K, Kumamoto T, et al: Involvement of dual strands of miR-143 (miR-143-5p and miR-143-3p) and their target oncogenes in the molecular pathogenesis of lung adenocarcinoma. Int J Mol Sci. 20:44822019. View Article : Google Scholar
23	Liu J, Li H, Shen S, Sun L, Yuan Y and Xing C: Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer. J Cancer. 9:1754–1764. 2018. View Article : Google Scholar : PubMed/NCBI
24	Wen R, Xiao Y, Zhang Y, Yang M, Lin Y and Tang J: Identification of a novel transcript isoform of the TTLL12 gene in human cancers. Oncol Rep. 36:3172–3180. 2016. View Article : Google Scholar : PubMed/NCBI
25	Massoner P, Lueking A, Goehler H, Höpfner A, Kowald A, Kugler KG, Amersdorfer P, Horninger W, Bartsch G, Schulz-Knappe P and Klocker H: Serum-autoantibodies for discovery of prostate cancer specific biomarkers. Prostate. 72:427–436. 2012. View Article : Google Scholar : PubMed/NCBI
26	Li H, Huang Y, Yu Y, Li G and Karamanos Y: Self-catalyzed assembly of peptide scaffolded nanozyme as a dynamic biosensing system. ACS Appl Mater Interfaces. 8:2833–2839. 2016. View Article : Google Scholar : PubMed/NCBI
27	Wasylyk C, Zambrano A, Zhao C, Brants J, Abecassis J, Schalken JA, Rogatsch H, Schaefer G, Pycha A, Klocker H and Wasylyk B: Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy. Int J Cancer. 127:2542–2553. 2010. View Article : Google Scholar : PubMed/NCBI
28	Robert BM, Dakshinamoorthy M, Ganapathyagraharam Ramamoorthy B, Dhandapani M, Thangaiyan R, Muthusamy G, Nirmal RM and Prasad NR: Predicting tumor sensitivity to chemotherapeutic drugs in oral squamous cell carcinoma patients. Sci Rep. 8:155452018. View Article : Google Scholar : PubMed/NCBI
29	Wood SC, Tang X and Tesfamariam B: Paclitaxel potentiates inflammatory cytokine-induced prothrombotic molecules in endothelial cells. J Cardiovasc Pharmacol. 55:276–285. 2010. View Article : Google Scholar : PubMed/NCBI
30	Zhou X, Wu J, Hao Y, Zhu C, Zhuo Q, Xia H and Zhu J: Rational design and synthesis of unsaturated se-containing osmacycles with σ-aromaticity. Chemistry. 24:2389–2395. 2018. View Article : Google Scholar : PubMed/NCBI
31	Ensafi AA, Dadkhah-Tehrani S and Karimi-Maleh H: Voltammetric determination of glutathione in haemolysed erythrocyte and tablet samples using modified-multiwall carbon nanotubes paste electrode. Drug Test Anal. 4:978–985. 2012. View Article : Google Scholar : PubMed/NCBI
32	Miyawaki A, Hijioka H, Ikeda R, Ishida T, Nozoe E and Nakamura N: Analysis of the outcome of concurrent neoadjuvant chemoradiotherapy with S-1 compared to super-selective intra-arterial infusion for oral squamous cell carcinoma. Oncol Lett. 3:995–1001. 2012. View Article : Google Scholar : PubMed/NCBI
33	Feng X, Luo Q, Zhang H, Wang H, Chen W, Meng G and Chen F: The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. J Exp Clin Cancer Res. 36:812017. View Article : Google Scholar : PubMed/NCBI
34	Kim J and Chan JJ: Cyclophosphamide in dermatology. Australas J Dermatol. 58:5–17. 2017. View Article : Google Scholar : PubMed/NCBI
35	Olasz L, Orsi E, Markó T and Szalma J: Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC). Cancer Metastasis Rev. 29:607–611. 2010. View Article : Google Scholar : PubMed/NCBI
36	Blanchard-Fillion B, Prou D, Polydoro M, Spielberg D, Tsika E, Wang Z, Hazen SL, Koval M, Przedborski S and Ischiropoulos H: Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. J Neurosci. 26:6124–6130. 2006. View Article : Google Scholar : PubMed/NCBI
37	Goodson HV and Jonasson EM: Microtubules and Microtubule-Associated Proteins. Cold Spring Harb Perspect Biol. 10:a0226082018. View Article : Google Scholar : PubMed/NCBI
38	Akhmanova A and Steinmetz MO: Control of microtubule organization and dynamics: Two ends in the limelight. Nat Rev Mol Cell Biol. 16:711–726. 2015. View Article : Google Scholar : PubMed/NCBI
39	Magiera MM, Singh P, Gadadhar S and Janke C: Tubulin posttranslational modifications and emerging links to human disease. Cell. 173:1323–1327. 2018. View Article : Google Scholar : PubMed/NCBI
40	Janke C and Montagnac G: Causes and consequences of microtubule acetylation. Curr Biol. 27:R1287–R1292. 2017. View Article : Google Scholar : PubMed/NCBI
41	Nieuwenhuis J and Brummelkamp TR: The tubulin detyrosination cycle: Function and enzymes. Trends Cell Biol. 29:80–92. 2019. View Article : Google Scholar : PubMed/NCBI
42	Kalisz HM, Erck C, Plessmann U and Wehland J: Incorporation of nitrotyrosine into alpha-tubulin by recombinant mammalian tubulin-tyrosine ligase. Biochim Biophys Acta. 1481:131–138. 2000. View Article : Google Scholar : PubMed/NCBI
43	Song W, Cho Y, Watt D and Cavalli V: Tubulin-tyrosine ligase (TTL)-mediated increase in tyrosinated α-tubulin in injured axons is required for retrograde injury signaling and axon regeneration. J Biol Chem. 290:14765–14775. 2015. View Article : Google Scholar : PubMed/NCBI
44	Rivelli JF, Ochoa AL, Santander VS, Nigra A, Previtali G and Casale CH: Regulation of aldose reductase activity by tubulin and phenolic acid derivates. Arch Biochem Biophys. 654:19–26. 2018. View Article : Google Scholar : PubMed/NCBI
45	Bajaj S, Roy PP and Singh J: 1,3,4-oxadiazoles as telomerase inhibitor: Potential anticancer agents. Anticancer Agents Med Chem. 17:1869–1883. 2018. View Article : Google Scholar : PubMed/NCBI
46	Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S and Paz-Ares L: Current challenges in cancer treatment. Clin Ther. 38:1551–1566. 2016. View Article : Google Scholar : PubMed/NCBI
47	De Marchi P, Melendez ME, Laus AC, Kuhlmann PA, de Carvalho AC, Arantes LMRB, Evangelista AF, Andrade ES, de Castro G Junior, Reis RM, et al: The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral Oncol. 98:48–52. 2019. View Article : Google Scholar : PubMed/NCBI
48	Fugazzola L, Muzza M, Pogliaghi G and Vitale M: Intratumoral genetic heterogeneity in papillary thyroid cancer: Occurrence and clinical significance. Cancers (Basel). 12:3832020. View Article : Google Scholar
49	Mimoto R, Yogosawa S, Saijo H, Fushimi A, Nogi H, Asakura T, Yoshida K and Takeyama H: Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells. Sci Rep. 9:134052019. View Article : Google Scholar : PubMed/NCBI
50	Hoffman RM and Tanino H: Clinical usefulness of the histoculture drug response assay for breast cancer. Methods Mol Biol. 1760:93–100. 2018. View Article : Google Scholar : PubMed/NCBI
51	Franck S, Fuhrmann-Selter T, Joseph JF, Michelet R, Casilag F, Sirard JC, Wicha SG and Kloft C: A rapid, simple and sensitive liquid chromatography tandem mass spectrometry assay to determine amoxicillin concentrations in biological matrix of little volume. Talanta. 201:253–258. 2019. View Article : Google Scholar : PubMed/NCBI
52	Wu CP, Lusvarghi S, Tseng PJ, Hsiao SH, Huang YH, Hung TH and Ambudkar SV: MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs. Am J Cancer Res. 10:164–178. 2020.PubMed/NCBI
53	Dhiman N, Kingshott P, Sumer H, Sharma CS and Rath SN: On-chip anticancer drug screening-recent progress in microfluidic platforms to address challenges in chemotherapy. Biosens Bioelectron. 137:236–254. 2019. View Article : Google Scholar : PubMed/NCBI
54	Mourelatos D: Sister chromatid exchange assay as a predictor of tumor chemoresponse. Mutat Res Genet Toxicol Environ Mutagen. 803:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
55	Zhang L, Li B, Zhang B, Zhang H and Suo J: miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer. Oncol Lett. 18:4064–4073. 2019.PubMed/NCBI
56	Sticozzi C, Aiello F, Andreasi RB, Muresan XM, Belmonte G, Cervellati F, Maellaro E, Maioli E and Valacchi G: Antitubulinic effect of new fluorazone derivatives on melanoma cells. Anticancer Agents Med Chem. 16:601–608. 2016. View Article : Google Scholar : PubMed/NCBI